Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $37.2M | $191M | $452M | $854M | $968M | $1.43B | $1.61B | $1.83B | $2.17B | $2.32B |
| Revenue growth | — | 415.0% | 136.3% | 88.7% | 13.3% | 48.3% | 12.3% | 13.6% | 18.5% | 7.0% |
| Operating income | -$121M | -$28.1M | $166M | $439M | $369M | $287M | $201M | $171M | $605M | $872M |
| Operating margin | -326.6% | -14.7% | 36.7% | 51.4% | 38.2% | 20.0% | 12.5% | 9.3% | 27.9% | 37.6% |
| Net income | -$162M | -$70.2M | $154M | $690M | $321M | $231M | $182M | $208M | $521M | $783M |
| Net margin | -435.1% | -36.7% | 34.1% | 80.8% | 33.2% | 16.1% | 11.3% | 11.4% | 24.0% | 33.7% |
| EPS (diluted) | -$0.77 | -$0.28 | $0.49 | $2.21 | $1.02 | $0.72 | $0.56 | $0.65 | $1.76 | $2.78 |
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$142M | $210M | $166M | $416M | $527M | $401M | $363M | $333M | $700M | $884M |
| Capital expenditures | $447K | $1.70M | $21.1M | $33.3M | $12.8M | $54.2M | $27.7M | $40.5M | $28.4M | $8.43M |
| Free cash flow | -$142M | $209M | $144M | $382M | $514M | $347M | $335M | $293M | $672M | $876M |
| Share buybacks | — | — | — | — | — | $0.00 | $0.00 | $550M | $652M | $948M |
| Fiscal year | FY2015 | FY2016 | FY2017 | FY2018 | FY2020 | FY2021 | FY2022 | FY2023 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $80.4M | $152M | $183M | $315M | $267M | $647M | $501M | $263M | $217M | $482M |
| Total assets | $332M | $596M | $655M | $1.42B | $1.89B | $2.62B | $3.07B | $2.94B | $2.95B | $2.84B |
| Total liabilities | $473M | $506M | $370M | $135M | $200M | $406M | $583M | $678M | $703M | $683M |
| Long-term debt | $418M | $189M | $0.00 | — | — | — | — | — | — | — |
| Shareholders' equity | -$159M | $89.3M | $285M | $1.29B | $1.69B | $2.21B | $2.49B | $2.26B | $2.24B | $2.16B |
| Retained earnings | -$1.91B | -$1.98B | -$1.83B | -$880M | -$559M | -$217M | -$34.2M | -$173M | -$98.6M | -$76.8M |
| Shares (wtd avg diluted) | 228M | 251M | 312M | 313M | 315M | 322M | 325M | 321M | 296M | 282M |
Every figure is extracted from EXELIXIS, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.